Status:
UNKNOWN
Novel Subtypes of Polycystic Ovary Syndrome
Lead Sponsor:
Shandong University
Conditions:
Polycystic Ovary Syndrome
Eligibility:
FEMALE
18-45 years
Brief Summary
To classify subtypes of Polycystic Ovary Syndrome (PCOS) using machine-learning algorithms, and compare the reproductive and metabolic characteristics and IVF outcomes across these identified subtypes...
Detailed Description
In this study, we've developed a machine-learning model to classify PCOS patients into four subtypes based on nine clinical characteristics. The goal of this observational study is to: * Learn about...
Eligibility Criteria
Inclusion
- PCOS patients diagnosed using the Rotterdam criteria, which requires the presence of at least two of the following:
- Menstrual Irregularities: A menstrual cycle length of fewer than 21 days or more than 35 days, and/or fewer than eight cycles per year.
- Hyperandrogenism: Defined either by an elevated total testosterone level (as per local laboratory criteria) or by a modified Ferriman-Gallwey (mFG) score of 5 or higher.
- Polycystic Ovaries on Ultrasound: Presence of 12 or more follicles measuring 2-9 mm in diameter in each ovary and/or an ovarian volume exceeding 10 mL.
Exclusion
- Patients with congenital adrenal hyperplasias, androgen-secreting tumours, or Cushing's syndrome) will be excluded.
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 30 2025
Estimated Enrollment :
50000 Patients enrolled
Trial Details
Trial ID
NCT06124391
Start Date
January 1 2021
End Date
December 30 2025
Last Update
November 30 2023
Active Locations (11)
Enter a location and click search to find clinical trials sorted by distance.
1
Penn State College of Medicine
Hershey, Pennsylvania, United States, 17033
2
Hospital de Clinicas de Porto Alegre
Porto Alegre, Brazil
3
Chengdu Jinjiang Maternity and Child Health Hospital
Chengdu, China
4
Guangdong Second Provincial General Hospital
Guangzhou, China